Get complete Patent Opposition Report for Sun Pharmaceutical Industries

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Sun Pharmaceutical Industries against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2234617Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 27, 2021
EP2478907Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYSep 13, 2021

Explore Sun Pharmaceutical Industries's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3137060Dec 20, 2023Extended Release Suspension Compositions1
EP3811927Feb 23, 2022A Stable Parenteral Dosage Form Of Cetrorelix Acetate1
EP3450434Feb 24, 2021Deuterated Derivatives Of Ruxolitinib1